Clinical Trial Capacity

The goal of ACTIV is to develop a research strategy for prioritizing and speeding development of the most promising COVID-19 vaccines and treatments.


The Clinical Trial Capacity Working Group is focused on:

  • Identifying data from different populations and disease stages
  • Leveraging infrastructure and expertise from across NIH and non-NIH networks and clinical research organizations
  • Establishing a coordinated mechanism across networks to expedite trials
  • Tracking incidence across sites and projecting future capacity